Attorney advertising — free, confidential case review
No fee unless you recover compensation

Olympus Scope Lawsuits: Answers to Common Questions

This page answers the questions people most often ask about the Olympus scope infection lawsuits. Each answer is short and links to a longer article where we go deeper. Every factual statement here is drawn from the sources listed at the bottom of the page, and statements about lawsuits describe allegations, not court findings.

How to read this page

The Olympus scope story has several parts that people often mix together:

  • The lawsuits are individual product liability cases filed by patients and families.
  • The FDA’s actions are regulatory steps, such as warning letters, import alerts and recalls, that concern how Olympus manufactures and reports on its devices.
  • The medical question is how well reusable scopes can be cleaned between patients, which the FDA has studied since 2015.

A development in one of these does not automatically decide the others, which is why several answers below begin by separating them.

Questions and answers

The questions are listed below. If you want the most recent developments, start with our monthly litigation status update, which we review and update every month.

Frequently asked questions

What are the Olympus scope lawsuits about?

Patients and families allege that an infection followed a procedure performed with a reusable Olympus scope, and that the scope could not be reliably cleaned between patients or that Olympus did not adequately warn about the risk. Many cases involve duodenoscopes used in ERCP. These are allegations, and courts have not made findings in most of the cases.

Which Olympus devices are named in the lawsuits?

Most complaints involve duodenoscopes. Older cases involved the TJF-Q180V, and a wrongful death complaint filed in June 2026 in federal court in Washington state involves the TJF-Q190V. Some complaints involve other reusable scopes, so the device used in your procedure matters.

Has Olympus been found liable?

In the first U.S. trial over scope-linked outbreaks, in Seattle in 2017, the jury found that Olympus failed to provide adequate warnings and instructions but rejected the claim that the scope’s design was unsafe. Separately, in December 2018 Olympus Medical Systems pleaded guilty to failing to file FDA-required adverse event reports about infections in Europe. That was a criminal case about reporting, not a ruling in a patient’s lawsuit. Many current cases are still pending. See what the 2017 verdict decided.

What does Olympus say about its scopes?

In 2017 reporting, Olympus said its gastrointestinal scopes were safe and effective with proper cleaning and disinfection, and at the 2017 trial it argued that the hospital did not follow its cleaning instructions.

Is there a class action or an MDL?

As of early November 2026, we found no report of a multidistrict litigation (MDL) for Olympus scope infection claims, and cases are proceeding individually in state and federal courts. The Judicial Panel on Multidistrict Litigation keeps the official list of pending requests. See our monthly status update.

What has the FDA said about duodenoscope cleaning?

In February 2015 the FDA said the elevator mechanism at the tip of duodenoscopes has microscopic crevices that are hard to clean, and that infections were reported even when facilities followed the manufacturer’s instructions. Later FDA-ordered studies reported higher-than-expected contamination after cleaning, while the agency also said the risk to an individual patient remains relatively low. See why duodenoscopes are hard to clean.

What is the difference between a warning letter, an import alert, and a recall?

A warning letter is a formal FDA notice that an inspection found violations, and it asks the company to respond. An import alert directs the FDA to refuse entry of listed products at the U.S. border, and the FDA says devices already in use may keep being used if they are working properly. A recall is a company’s action to remove or correct a product already in distribution, and the FDA sorts recalls by seriousness, with Class I the most serious.

Do the FDA’s October 2026 actions involve duodenoscopes?

The October 7 warning letter concerns quality systems at six Olympus facilities and does not discuss the duodenoscope infection claims. The import alert’s published model list, which now totals 63 models, does not include duodenoscopes. See our explainers on the warning letter and the import alert.

Who may be able to file a claim?

In general, people who had a procedure with an Olympus scope and then developed a serious infection, such as CRE, VRE or another drug-resistant infection, or families who lost a loved one to one. Only an attorney can say whether a particular case has merit, and that depends on the medical records and the facts.

How long do I have to file?

Each state sets its own time limits, called statutes of limitations, for product liability and wrongful death claims, and some states count from the date the injury was discovered. Deadlines can pass, so a prompt case review is important.

What compensation might be available?

Depending on the facts, damages in product liability and wrongful death claims can include medical expenses, lost income, pain and suffering, and funeral costs. No outcome is guaranteed, and past results do not predict future ones.

What should I do if I think a scope caused my infection?

Get medical care first. Keep your records, ask your provider for the procedure date, the facility, and the type of scope used if it is available, report device problems to the FDA’s MedWatch program, and consider a free, confidential case review.

Does a case review cost anything?

No. Case reviews are free and confidential, and these claims are handled on a contingency basis, which means there is no attorney fee unless your case results in a settlement or verdict.

Sources

  1. KFF Health News: Scope Maker Olympus Hit With $6.6 Million Verdict In Superbug Outbreak Case (July 2017)
  2. U.S. Department of Justice: Olympus Medical Systems Corporation, Former Senior Executive Plead Guilty to Distributing Endoscopes After Failing to File FDA-Required Adverse Event Reports of Serious Infections (December 10, 2018)
  3. FDA: Infections Associated with Reprocessed Duodenoscopes
  4. Healio: FDA says design of ERCP endoscopes may hinder effective cleaning (February 19, 2015)
  5. Healio: FDA warns of higher-than-expected contamination rates after duodenoscope reprocessing (January 17, 2019)
  6. FDA: Update: Import Alert for Certain Olympus Medical Devices Manufactured in Japan, Letter to Health Care Providers (October 20, 2026)
  7. FDA: Warning Letter to Olympus Medical Systems Corporation, CMS #729208 (October 7, 2026)
  8. Infection Control Today: Can Reusable Duodenoscopes Still Transmit Infections? New Olympus Lawsuit Alleges Fatal VRE Case

Facts in this article come from the sources listed above and were current when the article was published or last updated. Statements about lawsuits describe allegations, which are claims and not findings by a court.

This article is general information, not medical or legal advice. Reading it does not create an attorney-client relationship. If you have symptoms of an infection, contact your health care provider. Attorney advertising. Prior results do not guarantee a similar outcome.